Literature DB >> 3801773

Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices.

Y Goshima, T Kubo, Y Misu.   

Abstract

Effects of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices evoked by electrical field stimulation at 5 Hz were investigated in the absence and presence of p-bromobenzyloxyamine (NSD-1055), a DOPA-decarboxylase inhibitor. In the absence of NSD-1055, L-DOPA produced a facilitation of impulse-evoked release of noradrenaline at 0.1 microM but not at 1 and 10 microM, and had no effect on the spontaneous release. On the other hand, L-DOPA 0.1 to 10 microM dose-dependently increased the spontaneous release of dopamine and the highest concentration only increased the evoked release and tissue content of dopamine. In the presence of NSD-1055 10 microM, the increase in the spontaneous release of dopamine was prevented and L-DOPA produced biphasic regulatory effects on the evoked release of noradrenaline and dopamine, a facilitation at 0.1 microM and an inhibition at 1 microM. The facilitation was antagonized by (-)-propranolol 0.1 microM, but not by the (+)-isomer, whereas the inhibition was antagonized by S-sulpiride 1 nM, but not by the R-isomer. In conclusion, L-DOPA appears to produce biphasic actions on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices, not through its conversion to dopamine but through presynaptic regulatory mechanisms, an inhibition via dopamine receptors at a micromolar concentration and a facilitation via beta-adrenoceptors at the lower concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801773      PMCID: PMC1917033          DOI: 10.1111/j.1476-5381.1986.tb11139.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

Authors:  K G Lloyd; L Davidson; O Hornykiewicz
Journal:  J Pharmacol Exp Ther       Date:  1975-12       Impact factor: 4.030

3.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

Authors:  B S Bunney; G K Aghajanian; R H Roth
Journal:  Nat New Biol       Date:  1973-09-26

4.  The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.

Authors:  M F Lokhandwala; J P Buckley
Journal:  J Pharmacol Exp Ther       Date:  1978-02       Impact factor: 4.030

5.  Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.

Authors:  Y Misu; Y Goshima; H Ueda; T Kubo
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

6.  Does acute L-DOPA increase active release of dopamine from dopaminergic neurons?

Authors:  F Ponzio; G Achilli; C Perego; G Rinaldi; S Algeri
Journal:  Brain Res       Date:  1983-08-22       Impact factor: 3.252

7.  Dopamine: stimulation-induced release from central neurons.

Authors:  K Y Ng; T N Chase; R W Colburn; I J Kopin
Journal:  Science       Date:  1971-04-30       Impact factor: 47.728

8.  Presynaptic mediation by alpha 2-, beta 1- and beta 2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus.

Authors:  H Ueda; Y Goshima; Y Misu
Journal:  Life Sci       Date:  1983-07-25       Impact factor: 5.037

9.  Studies on tyrosine hydroxylase system in rat brain slices using high-performance liquid chromatography with electrochemical detection.

Authors:  Y Hirata; A Togari; T Nagatsu
Journal:  J Neurochem       Date:  1983-06       Impact factor: 5.372

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  9 in total

1.  The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Authors:  Y Hiroshima; H Miyamoto; F Nakamura; D Masukawa; T Yamamoto; H Muraoka; M Kamiya; N Yamashita; T Suzuki; S Matsuzaki; I Endo; Y Goshima
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

2.  Possibility of autocrine beta-adrenergic signaling in C2C12 myotubes.

Authors:  Jill L Smith; Pankaj B Patil; Shelley D Minteer; Jason R Lipsitz; Jonathan S Fisher
Journal:  Exp Biol Med (Maywood)       Date:  2005-12

Review 3.  Neurophysiology of the brain stem in Parkinson's disease.

Authors:  Cecilia Bove; R Alberto Travagli
Journal:  J Neurophysiol       Date:  2019-03-27       Impact factor: 2.714

4.  Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.

Authors:  Y Imazu; K Kobayashi; T Shohmori
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

5.  Dorsal striatal dopamine D1 receptor availability predicts an instrumental bias in action learning.

Authors:  Lieke de Boer; Jan Axelsson; Rumana Chowdhury; Katrine Riklund; Raymond J Dolan; Lars Nyberg; Lars Bäckman; Marc Guitart-Masip
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-18       Impact factor: 11.205

Review 6.  l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Authors:  Yoshio Goshima; Daiki Masukawa; Yuka Kasahara; Tatsuo Hashimoto; Aderemi Caleb Aladeokin
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

7.  Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia.

Authors:  Elva Fridjonsdottir; Reza Shariatgorji; Anna Nilsson; Theodosia Vallianatou; Luke R Odell; Luke S Schembri; Per Svenningsson; Pierre-Olivier Fernagut; Alan R Crossman; Erwan Bezard; Per E Andrén
Journal:  Sci Adv       Date:  2021-01-06       Impact factor: 14.136

Review 8.  The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.

Authors:  Beatriz Bueschbell; Prashiela Manga; Anke C Schiedel
Journal:  Front Mol Biosci       Date:  2022-04-12

9.  L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum.

Authors:  Gregory Porras; Philippe De Deurwaerdere; Qin Li; Matteo Marti; Rudolf Morgenstern; Reinhard Sohr; Erwan Bezard; Michele Morari; Wassilios G Meissner
Journal:  Sci Rep       Date:  2014-01-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.